Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using optical imaging summary data to detect glaucoma.

C Sanchez-Galeana1, C Bowd, E Z Blumenthal

  • 1Glaucoma Center, University of California San Diego, La Jolla, California 92093-0946, USA.

Ophthalmology
|October 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pandemic impacts and experiences after disaster in Australia: qualitative study of compound impacts following the Black Summer bushfires.

BJPsych open·2024
Same author

DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.

Cell death & disease·2015
Same author

Inhibition of cyclophilin D by cyclosporin A promotes retinal ganglion cell survival by preventing mitochondrial alteration in ischemic injury.

Cell death & disease·2014
Same author

Vascular tone pathway polymorphisms in relation to primary open-angle glaucoma.

Eye (London, England)·2014
Same author

Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes.

Cell death & disease·2013
Same author

A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics.

Cell death & disease·2011
Same journal

Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation/Loss in Eyes With Geographic Atrophy.

Ophthalmology·2026
Same journal

Access to Intravitreal Anti-VEGF Drugs in Persons with Medicare Advantage Compared with Medicare Fee-For-Service.

Ophthalmology·2026
Same journal

Re: Dones et al.: Emergency department use of ocular point-of-care ultrasound and its utility in diagnosis at a tertiary academic medical center (Ophthalmology. 2026;133:720-727).

Ophthalmology·2026
Same journal

Cataract Surgery and the Risk of Conversion from Dry to Neovascular Age-related Macular Degeneration in the IRIS© Registry.

Ophthalmology·2026
Same journal

Blunt Ocular Trauma from BB Gun Pellet: Long-Term Corneal Endothelial Changes.

Ophthalmology·2026
Same journal

Atypical Sebaceous Adenoma of the Caruncle.

Ophthalmology·2026
See all related articles

Heidelberg Retina Tomograph (HRT), GDx Nerve Fiber Analyzer (GDx), and Optical Coherence Tomograph (OCT) summary reports can distinguish glaucoma from normal eyes. However, their diagnostic accuracy is insufficient for early to moderate glaucoma screening.

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Glaucoma Diagnosis

Background:

  • Glaucoma is a progressive optic neuropathy characterized by visual field loss.
  • Early detection and accurate diagnosis are crucial for managing glaucoma and preventing vision impairment.
  • Advanced imaging technologies like HRT, GDx, and OCT provide quantitative data for glaucoma assessment.

Purpose of the Study:

  • To assess the diagnostic performance of summary data reports from HRT, GDx, and OCT in differentiating early to moderate glaucomatous eyes from normal eyes.
  • To determine the sensitivity and specificity of these imaging modalities when used individually.

Main Methods:

  • A comparative cross-sectional study involving 50 normal subjects and 39 glaucoma patients with early to moderate visual field damage.

Related Experiment Videos

  • Three masked, experienced graders independently evaluated summary data reports from HRT, GDx, and OCT.
  • Each report was classified as normal or glaucomatous, with sensitivity, specificity, and inter-grader agreement analyzed.

    • Main Results:

    • Heidelberg Retina Tomograph (HRT) showed sensitivity ranging from 64% to 75% and specificity from 68% to 80%.
    • GDx Nerve Fiber Analyzer (GDx) demonstrated sensitivity from 72% to 82% and specificity from 56% to 82%.
    • Optical Coherence Tomograph (OCT) yielded sensitivity from 76% to 79% and specificity from 68% to 81%.

    Conclusions:

    • Summary data reports from HRT, GDx, and OCT can differentiate between normal and glaucomatous eyes with mild to moderate visual field loss.
    • The sensitivity and specificity achieved by these instruments individually do not support their use as standalone screening tools for early to moderate glaucoma.